The Value of Botox-A Administered as a Single Intra-rectal Injection for the Management of Low Anterior Resection Syndrome: A Phase II Study

Trial Profile

The Value of Botox-A Administered as a Single Intra-rectal Injection for the Management of Low Anterior Resection Syndrome: A Phase II Study

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Feb 2018

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Gastrointestinal disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Feb 2018 Status changed from active, no longer recruiting to completed.
    • 11 May 2015 Planned End Date changed from 1 Sep 2015 to 1 Nov 2015, according to to ClinicalTrials.gov record.
    • 11 May 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Oct 2015, according to to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top